Decibel Therapeutics
Professor of Otology and Laryngology, Harvard Medical School and Director, Tillotson Cell Biology Unit, Massachusetts Eye and Ear.
This person is not in the org chart
This person is not in any offices
Decibel Therapeutics
Decibel Therapeutics, a clinical-stage biotechnology company, has established the world’s first comprehensive drug discovery, development, and translational research platform for hearing and balance disorders.